Breast cancer is a heterogeneous disease with diverse molecular subtypes, which can be categorized into five distinct groups based on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2) and nuclear protein Ki-67 (2, 3). This evidence concerns the gene ERBB2 and breast carcinoma.